FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

773879000: Antineoplastic therapeutic role (role)

Status: current, Primitive. Date: 31-Jan 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3726859011 Antineoplastic therapeutic role en Synonym Active Case insensitive SNOMED CT core
3726860018 Antineoplastic therapeutic role (role) en Fully specified name Active Case insensitive SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Antineoplastic therapeutic role Is a Therapeutic role true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Avapritinib only product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Avapritinib-containing product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Trastuzumab deruxtecan-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Trastuzumab deruxtecan only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Trastuzumab deruxtecan-containing product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Trastuzumab deruxtecan only product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Enfortumab vedotin only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Enfortumab vedotin-containing product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Enfortumab vedotin-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Enfortumab vedotin only product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Tazemetostat only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Tazemetostat-containing product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Tazemetostat-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Tazemetostat only product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Isatuximab-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Isatuximab only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Isatuximab-containing product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Isatuximab only product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Ibrutinib 140 mg oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Some
Ibrutinib-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Ibrutinib-containing product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Ibrutinib only product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Ibrutinib only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Palbociclib 125 mg oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Some
Palbociclib only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Palbociclib only product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Palbociclib-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Palbociclib-containing product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Panobinostat (as panobinostat lactate) 15 mg oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Some
Panobinostat (as panobinostat lactate) 10 mg oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Some
Ixazomib (as ixazomib citrate) 4 mg oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Some
Ixazomib-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Ixazomib only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Panobinostat (as panobinostat lactate) 20 mg oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Some
Ixazomib (as ixazomib citrate) 3 mg oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Some
Ixazomib (as ixazomib citrate) 2.3 mg oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Some
Cabozantinib (as cabozantinib s-malate) 20 mg oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Some
Cabozantinib only product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Cabozantinib-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Cabozantinib-containing product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Cabozantinib only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Palbociclib 75 mg oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Some
Palbociclib 100 mg oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Some
Cabozantinib (as cabozantinib s-malate) 80 mg oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Some
Durvalumab only product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Durvalumab only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Durvalumab-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Durvalumab-containing product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Encorafenib only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Encorafenib only product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Encorafenib-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Encorafenib-containing product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Selumetinib-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Selumetinib only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Selumetinib-containing product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Selumetinib only product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Selumetinib 25 mg oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Some
Selumetinib 10 mg oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Some
Pemigatinib 4.5 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Pemigatinib 9 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Pemigatinib 13.5 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Pemigatinib only product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Pemigatinib-containing product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Pemigatinib only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Pemigatinib-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Tucatinib 50 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Tucatinib 150 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Tucatinib only product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Tucatinib-containing product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Tucatinib only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Tucatinib-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Sacituzumab govitecan-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Sacituzumab govitecan only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Sacituzumab govitecan-containing product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Sacituzumab govitecan only product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Olaparib only product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Olaparib 150 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Olaparib 100 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Olaparib-containing product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Olaparib only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Olaparib-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Niraparib only product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Niraparib only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Niraparib-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Niraparib-containing product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Rucaparib only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Rucaparib only product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Rucaparib-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Rucaparib-containing product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Nivolumab-containing product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Nivolumab only product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Nivolumab only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Nivolumab-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Ipilimumab-containing product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Ipilimumab only product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Ipilimumab only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Ipilimumab-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Atezolizumab only product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Atezolizumab-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Atezolizumab-containing product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Atezolizumab only product Plays role True Antineoplastic therapeutic role Inferred relationship Some

Start Page 2 of 16 Next End

Reference Sets

Qualifier value foundation reference set

Back to Start